ACTRN12616000727448
Recruiting
未知
Cardiac MRI in the prediction of outcomes in advanced cardiomyopathy
Baker IDI Heart and Diabetes Institute0 sites240 target enrollmentJune 2, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Baker IDI Heart and Diabetes Institute
- Enrollment
- 240
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Age \> 18
- •2\.Capable of giving informed consent
- •3\.New or established ICM or NICM (LVEF \< or \= 45%) as detected on any cardiac imaging (echocardiogram, nuclear medicine scan, other cardiac MRI, LV angiogram)
Exclusion Criteria
- •1\.Unable to consent to study
- •2\.Contraindication to cardiac MRI (eg, existing ICD, uncontrollable claustrophobia, inability to lie flat, proven or suspected metallic implant)
- •3\.eGRF \< 35ml/min or Cr \> 220
- •4\.Pregnancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Potential Ability of Cardiac MRI to Predict Efficacy after Cardiac Resynchronization TherapyHeart failureJPRN-UMIN000036415Tokai University Hospital130
Active, not recruiting
Not Applicable
fMRI in CardiaC arrEst With Uncertain PrognosisCardiac ArrestNCT06423768Brigham and Women's Hospital50
Completed
Not Applicable
Cardiac side effects of chemotherapy with anthracyclines in sarcoma patients assessed by cardiac MRIAnthracycline-induced cardiomyopathy in patients with sarcomaInjury, Occupational Diseases, PoisoningISRCTN12210850Charité University Medicine Berlin60
Recruiting
Phase 2
Cardiac Magnetic Resonance for the PREdiction and DIagnostiCs of hearT failureI50.1Left ventricular failureDRKS00016614Institut für Biomedizinische Technik (IBT) der Universität und ETH Zürich50
Completed
Not Applicable
CMR for Prognosis Assessment in NSTEMIMyocardial InfarctionNCT03516578Heart Center Leipzig - University Hospital314